http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019189565-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 |
filingDate | 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0701d12464b26ceb9fd30c9e0361bfa6 |
publicationDate | 2019-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019189565-A |
titleOfInvention | Pharmaceutical formulation |
abstract | The present invention provides a pharmaceutical preparation containing an isoquinoline-6-amino derivative that is stable even at high temperatures. An aqueous composition containing (A) a compound of the following formula (including tautomers) or a salt thereof or a solvate thereof and (B) prostaglandins is contained in a transparent container. A pharmaceutical preparation. (R 1 and R 2 are each independently H or a C 1 -C 4 alkyl group; R 3 is H or OH; A is —CH (R 4 ) — or —CH 2 —CH (R 4 ) —; R 4 may have a substituent C 6 -C 10 aryl group, or an optionally substituted 5-10 membered heteroaryl group) [Selection figure] None |
priorityDate | 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.